15164311000001100: Prezista 400mg tablets (Janssen-Cilag Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Prezista 400mg tablets (Janssen-Cilag Ltd)
\UK product\Virtual medicinal product\Darunavir 400mg tablets\Prezista 400mg tablets (Janssen-Cilag Ltd)
\UK product\Virtual therapeutic moiety\Darunavir\Darunavir 400mg tablets\Prezista 400mg tablets (Janssen-Cilag Ltd)
\UK product\Trade family\Prezista\Prezista 400mg tablets (Janssen-Cilag Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing darunavir\Darunavir\Darunavir 400mg tablets\Prezista 400mg tablets (Janssen-Cilag Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing carbamate\Product containing darunavir\Darunavir\Darunavir 400mg tablets\Prezista 400mg tablets (Janssen-Cilag Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing sulfonamide\Product containing darunavir\Darunavir\Darunavir 400mg tablets\Prezista 400mg tablets (Janssen-Cilag Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing sulfonamide\Product containing darunavir\Darunavir\Darunavir 400mg tablets\Prezista 400mg tablets (Janssen-Cilag Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing darunavir\Darunavir\Darunavir 400mg tablets\Prezista 400mg tablets (Janssen-Cilag Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

53553201000001110 Prezista 400mg tablets (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

53553301000001118 Prezista 400mg tablets (Janssen-Cilag Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Prezista 400mg tablets (Janssen-Cilag Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	Is a	Darunavir 400mg tablets	true	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	Is a	Darunavir 400mg tablets	false	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	Has specific active ingredient	Darunavir	true	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	Is a	Darunavir 400mg tablets	false	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	Is a	Prezista	true	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Darunavir	false	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	Has specific active ingredient	Darunavir ethanolate	false	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	Has active ingredient	Darunavir	false	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	Is a	Product containing precisely darunavir 400 milligram/1 each conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Prezista 400mg tablets (Janssen-Cilag Ltd)	Has basis of strength substance	Darunavir	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Prezista 400mg tablets (Janssen-Cilag Ltd) 60 tablet	Has AMP	True	Prezista 400mg tablets (Janssen-Cilag Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
53553201000001110	Prezista 400mg tablets (Janssen-Cilag Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
53553301000001118	Prezista 400mg tablets (Janssen-Cilag Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module